By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ampio Pharmaceuticals, Inc. 

5445 DTC Parkway, P4

Greenwood Village  Colorado  80111  U.S.A.
Phone: 303-418-1000 Fax: 303-418-1001


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ampio Pharmaceuticals, Inc. (AMPE)'s OptimEyes Study Results To Be Presented At The Association for Research in Vision & Ophthalmology 1/26/2016 8:08:14 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces 2016 Corporate Update On Thursday, January 28, 4:30pm EST 1/25/2016 7:50:11 AM
Ampio Pharmaceuticals, Inc. (AMPE)'s OptimEyes Study Results To Be Presented At World Ophthalmology Congress 1/11/2016 11:41:29 AM
The NYSE Establishes January 5, 2016 As The Ex-Distribution Date For The Ampio Pharmaceuticals, Inc. (AMPE) Distribution Of Aytu Bioscience Stock To Ampio Shareholders 12/1/2015 6:54:21 AM
Aytu Bioscience To Benefit From Share Distribution By Ampio Pharmaceuticals, Inc. (AMPE) 11/19/2015 7:21:08 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Investor Call On Its Aytu Bioscience Common Stock Distribution On Thursday, November 19, 4:15 P.M. Estcolon Cancer Test 11/18/2015 8:14:17 AM
Ampio Pharmaceuticals, Inc. (AMPE) Will Distribute Aytu Biosciences Stock To Ampio Shareholders Of Record On December 1, 2015 11/17/2015 9:44:44 AM
Ampio Pharmaceuticals, Inc. (AMPE) Intends To Distribute Aytu Bioscience Stock To Ampio Shareholders 11/2/2015 6:56:34 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Updates On the Regulatory Path for FDA Approval of Optina, an Oral Treatment for Diabetic Macular Edema (DME) 10/14/2015 7:28:20 AM
Ampio Pharmaceuticals, Inc. (AMPE) Receives Special Protocol Assessment (SPA) From The FDA And Commences Second Phase III Pivotal Trial Of Ampion 9/23/2015 10:04:13 AM
12345678910...
//-->